Effects of Exercise-intensity on Physiological Adaptations in Overweight and Obese (TRENO)
This study has been completed.
Sponsor:
Norwegian University of Science and Technology
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01453972
First received: October 10, 2011
Last updated: April 9, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The main purpose of our study is to examine the physiological adaptations in oxygen transport chain for high-intensity exercise and moderate exercise in overweight and obese humans. The main goals are:
- To investigate the most effective short-and long-interval training in terms of VO2max, pulmonary diffusion, cardiac output, endothelial function and mitochondrial function.
- How these physiological adaptations affect the aerobic endurance and performance, and how this training can reduce the risk of cardiovascular diseases related to overweight and obesity.
| Condition | Intervention |
|---|---|
|
Overweight Obesity |
Behavioral: Long distanse moderate training Behavioral: Long interval training Behavioral: Short interval training |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Effects of Exercise-intensity on Physiological Adaptations in Overweight and Obese |
Resource links provided by NLM:
Further study details as provided by Norwegian University of Science and Technology:
Primary Outcome Measures:
- Maximal oxygen uptake [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]Change in maximal oxygen uptake will be measured after six weeks of various exercise training and related to changes in blood volume, cardiac function, endothelial function and mitochondrial function.
| Enrollment: | 30 |
| Study Start Date: | October 2011 |
| Study Completion Date: | December 2012 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Long distanse moderate training
40 minutes moderate treadmill running
|
Behavioral: Long distanse moderate training
Moderate exercise
|
|
Experimental: Long interval training
4x4min interval treadmill running
|
Behavioral: Long interval training
High-intensity exercise, long duration
|
|
Experimental: Short interval training
10x1min interval treadmill running
|
Behavioral: Short interval training
High intensity exercise, short duration
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- BMI > 25
Exclusion Criteria:
- Exclusion criteria will be cardiovascular disease or another disease that is not consistent with high physical activity. Subjects should not have exercised regularly before the study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01453972
Locations
| Norway | |
| Medical Faculty, Norwegian University of Science and Technology | |
| Trondheim, Sør-Trøndelag, Norway, 7491 | |
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
| Principal Investigator: | Øivind Rognmo, PhD | Norwegian University of Science and Technology |
More Information
No publications provided
| Responsible Party: | Norwegian University of Science and Technology |
| ClinicalTrials.gov Identifier: | NCT01453972 History of Changes |
| Other Study ID Numbers: | TRENO |
| Study First Received: | October 10, 2011 |
| Last Updated: | April 9, 2013 |
| Health Authority: | Norway: Regional Ethics Commitee |
Keywords provided by Norwegian University of Science and Technology:
|
Exercise High-intensity Interval training |
Additional relevant MeSH terms:
|
Obesity Overweight Overnutrition |
Nutrition Disorders Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 23, 2013